Figures indicate number of patients dying of the complication. † P value for comparison of complications. ‡ Subarachnoid hemorrhage due to rupture of a coincidental cerebral artery aneurysm.
Objective
To evaluate the perioperative outcomes and long-term survival of extended hepatic resection for hepatocellular carcinoma (HCC) in patients with cirrhosis.
Summary Background Data
Hepatic resection is a well-established treatment for HCC in cirrhotic patients with preserved liver function and limited disease. However, the role of extended hepatic resection (more than four segments) for HCC in cirrhotic patients has not been elucidated.
Methods
Between 1993 and 2000, 45 consecutive patients with histologically confirmed cirrhosis underwent right or left extended hepatectomy for HCC (group A). Perioperative outcomes and long-term survival of these patients were compared with 161 patients with HCC and cirrhosis who underwent hepatic resection of a lesser extent in the same period (group B). All clinicopathologic and follow-up data were collected prospectively.
Results
Group A patients had significantly higher intraoperative blood loss, longer operation time, and longer hospital stay than group B. However, the two groups were similar in overall morbidity and hospital mortality. There were no significant differences in the incidence of liver failure or other complications. The resection margin width was similar between the two groups. Despite significantly larger tumor size in group A compared with group B, long-term survival was comparable between the two groups.
Conclusions
Extended hepatic resection for HCC can be performed in selected cirrhotic patients with acceptable morbidity, mortality, and long-term survival that are comparable to those of lesser hepatic resection. Extended hepatectomy for large HCC extending from one lobe to the other or central HCC critically related to the hepatic veins is justifiable in cirrhotic patients with preserved liver function and adequate liver remnant.
Hepatic resection is widely accepted as the treatment of choice for hepatocellular carcinoma (HCC). However, the majority of patients with HCC have underlying cirrhosis, which may limit the possibility of surgical treatment. Over the past two decades, the role of surgical management of HCC in patients with cirrhosis has progressed from limited resection for small HCCs to major hepatic resection for large tumors. [1] [2] [3] [4] [5] In the 1980s, the operative mortality of major hepatectomy among cirrhotic patients was as high as 32% in our institution, 6 but a more recent study from our center in the 1990s revealed a mortality rate of 13%, which was similar to that of patients without cirrhosis. 4 Other authors also demonstrated that major hepatic resection for HCC, mainly in the form of classical right or left hepatectomy, was associated with acceptable operative mortality in cirrhotic patients. 3, 5 With the current standard of surgical techniques and perioperative care, a more aggressive surgical treatment of HCC with extended hepatic resection (resection of more than four liver segments) may be justified in selected patients with cirrhosis. However, there was a paucity of data in the literature on extended hepatic resection for HCC in cirrhotic patients. In recent series that demonstrated favorable perioperative outcomes and long-term survival after resection of HCC in cirrhotic patients, most patients had minor liver resection, and none of the cirrhotic patients in these series underwent extended hepatectomy. [7] [8] [9] [10] Extended hepatic resection is a major surgical procedure that carries substantial operative risk. A previous study of 25 patients who underwent extended hepatectomy for HCC before 1990 reported a 30-day mortality rate of 12%. 11 In that study, however, most patients had noncirrhotic liver. A recent study of 226 patients with extended hepatic resection for various benign and malignant diseases from a major center reported a hospital mortality rate of 6.2%, but only 5 patients had cirrhosis in that series. 12 It remains unclear whether extended hepatic resection is safe in cirrhotic patients, and it is also unknown whether extended hepatic resection for HCC associated with cirrhosis is effective in providing long-term survival. Based on data prospectively collected in a computerized HCC database, we performed a retrospective study of a cohort of cirrhotic patients who underwent resection of HCC to evaluate the perioperative and long-term outcomes associated with extended hepatic resection.
METHODS
Between January 1993 and December 2000, 425 patients underwent hepatic resection for HCC at the Department of Surgery of Queen Mary Hospital, Hong Kong. Of these patients, 206 had histologically proven cirrhosis, including 174 men and 32 women (mean age 54.2 Ϯ 12.2 years). One hundred seventy-eight (86%) of these 206 patients had hepatitis B-related cirrhosis and HCC. Only eight (3.9%) patients were positive for hepatitis C antibody.
Preoperative assessment included ultrasonography, computed tomography (CT) scan, or arteriography to evaluate resectability. With the availability of helical CT scan in recent years, hepatic arteriography was seldom performed. The criteria for resection were absence of distant metastasis, absence of inferior vena cava or main portal vein tumor thrombus, and anatomically resectable disease (ie, macroscopic tumor clearance could be achieved with anatomical resection including extended hepatectomy). Hepatic function was assessed by the Child-Pugh classification, 13 liver biochemistry, and indocyanine green (ICG) clearance test. A previous study from our institution identified an ICG retention at 15 minutes (ICG-R15) of less than 14% as the safety limit for major hepatic resection, which was defined as resection of three or more segments of liver. 4 While this has been used as a guide in assessing patients for major hepatectomy, in recent years selected patients with a ICG-R15 of more than 14% were offered major hepatectomy if their general condition was good, liver biochemistry was satisfactory, and the size of the liver remnant was considered adequate. 14 CT scan was used for preliminary assessment of the size of the expected liver remnant, but we did not use CT volumetry to measure the exact volume of the liver remnant. Since June 1994, laparoscopy and laparoscopic ultrasound were routinely performed to confirm resectability before laparotomy. 15 Apart from the evaluation of the tumor status, laparoscopy played an important role in assessing the adequacy of the liver remnant size and the severity of cirrhosis when extended liver resection was contemplated in cirrhotic patients. Laparoscopic ultrasound allowed delineation of the extent of the tumor, its relationship to the main hepatic veins and portal vein branches, and any additional tumor nodules that needed to be encompassed, thus helping to establish the extent of resection. Patients with a small liver remnant or severe cirrhotic change on laparoscopy were excluded from extended hepatectomy. Figure 1 shows an algorithm depicting our decision strategy in selecting patients for extended hepatectomy.
The general techniques of hepatectomy in our center have been reported elsewhere. 16 Technical aspects that are relevant to extended hepatectomy are described here. Intraoperative ultrasound was routinely performed again after lap- Extended Hepatectomy for HCC in Cirrhosis arotomy to detect tumor invasion into major venous branches or additional tumor nodules in the contralateral lobe, and to mark the line of parenchymal transection aiming at a tumor-free margin. In right extended hepatectomy, the exact position of the middle hepatic vein joining the left hepatic vein or inferior vena cava was noted on ultrasound to avoid injury to the left hepatic vein during transection. To avoid bile duct injuries, especially during left extended hepatectomy, an operative cholangiogram was performed to identify any aberrant arrangements of the right anterior and posterior hepatic ducts in relation to the left hepatic duct. Parenchymal transection was accomplished using an ultrasonic dissector after control of the ipsilateral inflow vessels and mobilization of the ipsilateral lobe. Extrahepatic dissection of the hepatic duct was avoided. Rather, the hepatic duct was isolated and ligated or sutured at the time of hepatic transection. Recently, we have used an endoscopic vascular linear cutter (Ethicon Endo-surgery, Cincinnati, OH) that staples the two ends at the same time of cutting to divide the hepatic duct pedicle. In right extended hepatectomy, the right hepatic vein was isolated extrahepatically and divided before parenchymal transection in most cases, but the middle hepatic vein was usually controlled within the liver during transection. In left extended hepatectomy, the left and middle hepatic veins were controlled as a common trunk or individually before transection if possible; otherwise they were controlled at the time of parenchymal transection. The endovascular linear cutter has also been used to divide hepatic veins extrahepatically or intrahepatically in recent years. In patients with exceptionally large right lobe tumors that make mobilization and rotation of the right lobe difficult, particularly those with infiltration into the diaphragm, an anterior approach with parenchymal transection before mobilization of the right lobe was adopted. 17 Intermittent clamping of the portal triad for 15 minutes and release for a 5-minute interval was applied in some patients, but total vascular exclusion was not used. The bile leakage test was performed using methylene blue injection via a cystic duct cannula after transection, and any leakage site at the hepatic duct stump or transection surface was carefully repaired with fine sutures. The falciform ligament was reconstituted after right extended hepatectomy to prevent the remnant liver from falling into right subphrenic space, which could lead to postoperative liver failure by twisting the left hepatic vein. 18 All patients were monitored in the intensive care unit after operation, with attention to fluid balance, oxygenation, and tissue perfusion. All patients received intravenous albumin 50 g daily for 5 days and broad-spectrum antibiotics for at least 3 days. After a previous randomized study from our department that demonstrated a benefit in perioperative total parenteral nutrition support, 19 parenteral nutrition consisting of branched chain amino acid-enriched solution, low-dose dextrose, medium-and long-chain triglycerides, phosphate, and multivitamin was started immediately after major hepatectomy in all cirrhotic patients. Oral nutrition was encouraged once bowel sounds returned. An oral preparation of branched-chain amino acid-enriched nutritional supplement (Aminoleban EN, Otsuka Pharmaceutical Co. Ltd., Seoul, Korea) was given in addition to the usual diet.
For the purpose of this study, the 206 patients with cirrhosis who underwent hepatic resection were divided into two groups. Group A (n ϭ 45) had extended hepatic resection, defined as resection of more than four liver segments. 11, 12 Group B (n ϭ 161) had resection of a lesser extent. The extent of hepatic resection was described using Couinaud's definition of liver segments. 20 Right extended hepatectomy referred to right hepatectomy (segments V-VIII) extended to segment IV, and left extended hepatectomy referred to left hepatectomy (segments II-IV) extended to segments VIII and V. In addition, the caudate lobe (segment I) was resected in some cases for tumor clearance. The main indication for extended hepatectomy was a large tumor extending across the Cantlie's line from one lobe to the other (Fig. 2 ). Occasionally, extended hepatectomy was performed for smaller but critically located posterior tumors that were closely related to or invaded into middle hepatic vein ( Fig. 3 ).
The clinicopathologic, intraoperative, and postoperative data of all patients were collected and entered prospectively into a computerized database. Hospital mortality was defined as any death that occurred during the same hospital admission for the hepatic resection. All surviving patients were regularly followed by the same surgical team in an HCC clinic, with surveillance for recurrence by serial alphafetoprotein level and ultrasonography or CT scan every 3 months. The follow-up status and any recurrence were regularly updated in the database for each patient. We did not give preoperative transarterial chemoembolization as a neoadjuvant therapy, but a few patients received the treatment before referral to our department. Postoperative adjuvant chemotherapy was not given except in a few patients (four in group A, eight in group B) recruited in a previous randomized controlled trial of postoperative transarterial chemotherapy, which showed no benefit of the adjuvant treatment. 21 The clinicopathologic features, postoperative complications, hospital mortality, and long-term survival results of group A were compared with those of group B. Continuous variables were expressed as mean Ϯ standard deviation and compared using the unpaired t test. Categorical variables were compared by the chi-square test with Yates' correction or the Fisher exact test where appropriate. Long-term overall and disease-free survivals were computed using the Kaplan-Meier method and compared by the log-rank test. Hospital deaths were included in overall survival analysis but were excluded from disease-free survival analysis. All statistical analyses were performed using statistical software (SPSS 9.05 for Windows, SPSS, Inc., Chicago, IL). Results were considered significant at P Ͻ .05.
RESULTS
In group A, 34 patients had right extended hepatectomy and the other 11 had left extended hepatectomy (Table 1 ). In group B, 61 patients had classical right (segments V-VIII) or left (segments II-IV) hepatectomy, whereas the other 100 had minor resection (two or fewer segments). Concomitant partial resection of the diaphragm due to tumor invasion was performed in 7 (16%) patients in group A and 12 (7.5%) patients in group B. Table 2 shows comparisons of the preoperative clinical data of the two groups. No significant differences were Computed tomography scan shows a 5-cm hepatocellular carcinoma with irregular border straddling segments VIII and IV. The tumor was infiltrating around the middle hepatic vein near its junction with the inferior vena cava (A, arrow). Scan at a 10-mm lower cut shows that the tumor was encroaching on the left hepatic vein (B, arrow). Intraoperative ultrasound confirmed similar findings. In addition, it revealed a tumor thrombus in the middle hepatic vein and tumor infiltration into the caudate lobe. The tumor was resected by left extended hepatectomy and caudate lobectomy. By the time of data analysis, the patient was alive without recurrence 46 months after surgery. Extended Hepatectomy for HCC in Cirrhosis observed in age, gender, or prevalence of comorbid illnesses. The two groups were comparable in various liver function parameters, except that there was a trend towards a more favorable ICG-R15 in group A (P ϭ .06). Only a small proportion of patients in each group had received preoperative transarterial chemoembolization.
Preoperative Data

Intraoperative and Postoperative Data
The intraoperative and postoperative data are summarized in Table 3 . Intraoperative blood loss was significantly higher in group A, and a higher proportion of patients in group A required transfusion compared with group B. Group A patients had a longer operating time and hospital stay than group B, and more patients in group A were supported with postoperative mechanical ventilation and parenteral nutrition. However, the overall morbidity (31% vs. 36%) and hospital mortality (6.7% vs. 5.0%) were comparable between group A and group B. Table 4 depicts the complications in each group. There were no significant differences between group A and group B in any of the complications. The two most common complications were wound infection and pleural effusion. The morbidity rate was similar after right extended hepatectomy (32%) or left extended hepatectomy (27%) (P ϭ .75). There was no significant difference in hospital mortality rate between patients with right extended hepatectomy (n ϭ 2, 5.9%) and those with left extended hepatectomy (n ϭ 1, 9.1%) (P ϭ .71). Two (4.8%) hospital deaths occurred in 42 Child-Pugh class A patients, and one death (33%) occurred in 3 Child-Pugh class B patients. Eight hospital deaths occurred in group B, six after right hepatectomy and two after minor hepatectomy. The main causes of death in each group are shown in Table 4 .
Pathologic Data
Group A patients had significantly larger tumors than group B (mean 8.3 vs. 4.8 cm, P Ͻ .001). The size of the tumors in group A ranged from 3 to 17.5 cm, with the majority of tumors more than 5 cm (n ϭ 33, 73%). Eighteen patients in group A had tumors larger than 10 cm. Group A also had higher proportions of tumors with absence of tumor capsule, presence of venous invasion, presence of microsatellite lesion, and tumors of advanced pTNM stage (Table 5 ). There was no significant difference in the resection margin width or rate of positive microscopic margin between group A and group B. 
Long-Term Survival
The median follow-up of this cohort of patients was 42 months (range 7-100). Overall survival was not significantly different between group A and group B (Fig. 4) . The 1-, 3-, and 5-year survival rates of group A were 70%, 50%, and 33%, respectively (median survival 42 months). For group B patients, the 1-, 3-, and 5-year survival rates were 79%, 54%, and 44%, respectively (median survival 44 months). Even for the 18 patients with HCC larger than 10 cm in group A, the overall survival (1-year 54%, 3-year 44%, 5-year 30%) was not significantly worse than that of group B (P ϭ .14). By the time of analysis, 23 (51%) of group A and 75 (47%) of group B patients had died, inclusive of hospital deaths. The causes of late deaths in group A were tumor recurrence (n ϭ 15), liver failure or variceal bleeding without recurrence (n ϭ 4), and unrelated comorbid illness (n ϭ 1). Among the 67 late deaths in group B, 50 were due to tumor recurrence, 12 to cirrhotic complications, and 5 to unrelated conditions. There was also no significant difference in disease-free survival between the two groups (Fig. 5) . The 1-, 3-, and 5-year disease-free survival rates of group A were 43%, 23%, and 18%, respectively (median disease-free survival 8.6 months). The 1-, 3-, and 5-year disease-free survival rates of group B patients were 54%, 32%, and 20%, respectively (median disease-free survival 14.5 months). By the time of analysis, 28 (67%) patients in group A and 90 (59%) patients in group B had developed tumor recurrence.
DISCUSSION
To our knowledge, this is the first study that evaluated the perioperative outcomes and long-term survival after extended hepatic resection for HCC in patients with cirrhosis. Despite recent advances in surgical techniques and periop-erative management, hepatic resection in cirrhotic liver remains a major challenge for surgeons because of the specific risks associated with cirrhosis, such as difficult mobilization and transection of the fibrotic liver, increased bleeding as a result of portal hypertension, and higher risk of liver failure. 23, 24 Mortality rates of 13% to 15% have been reported in some recent series of hepatic resection in cirrhotic liver that consisted of mainly minor hepatectomies for HCCs smaller than 5 cm. [25] [26] [27] This underscores the risk of hepatic resection in patients with cirrhosis. More favorable results have been reported from some centers, and major hepatic resection has been shown to be a safe and effective treatment for HCC in cirrhotic patients with preserved liver function. [3] [4] [5] 28 While it is generally accepted that classical right or left hepatectomy is justified for resection of HCC in cirrhotic patients, extended hepatectomy is seldom recommended. 24, 29 Liver failure remains a common complication, with a high risk of death, after major hepatic resection in patients with cirrhosis. 30 Cirrhotic patients who have extended hepatectomy are at a higher risk because of the limited regenerative capacity of the liver remnant, 31 which may be aggravated by increase in portal pressure after extensive liver resection. 32 Extended hepatectomy is technically more complex than classical right or left hepatectomy, with a higher risk of bleeding and complications even in noncirrhotic liver. 12, 33 Hence, it is important to document the perioperative outcomes and elucidate the risk associated with extended hepatic resection in cirrhotic patients. By comparing with the results of hepatic resection of a lesser extent, this study demonstrates that extended hepatectomy for HCC is justifiable in selected patients with cirrhosis.
The overall morbidity and mortality rates of group A were similar to those of group B. When compared with the previous mortality rates of major hepatic resection in cirrhotic patients in the 1980s and early 1990s in our institu- tion, 4,6 the hospital mortality rate of 6.7% after extended hepatectomy in the current study represents a major improvement. This mortality rate is comparable to that of 5% to 8% in recent series of hepatic resection in cirrhotic patients comprising mainly minor hepatectomies. 7, 34, 35 The morbidity rate of 31% after extended hepatectomy is also comparable to the reported morbidity rate of about 30% after hepatic resection in cirrhotic patients. 9, 10, 28, 29 Despite more extensive hepatic resection, there were no significant differences in the frequency of liver failure or other complications in group A. This may be attributable to careful patient selection, as reflected by the more favorable ICG-R15 in group A, though the two groups were similar in other liver function parameters. In a previous study, we have shown that ICG-R15 was better than liver biochemistry and Child-Pugh classification in assessing the operative risk of major hepatectomy in cirrhotic patients. 4 In addition to the evaluation of liver function, the amount of nontumorous liver parenchyma to be resected and the size of the liver remnant are important considerations in selecting cirrhotic patients for extended hepatic resection. Patients who require extended hepatic resection often have large tumors replacing most of the affected lobe, and thus removal of the involved lobe may not result in substantial loss of functioning parenchyma. The size of the expected liver remnant can be assessed by preoperative CT scan. CT volumetry has been used for quantitative estimation of liver remnant volume. 36 A recent study showed that a small liver remnant volume was associated with worse postoperative liver function and a higher complication rate after extended hepatectomy in normal liver. 37 However, the predictive value of liver volume on postoperative morbidity and mortality in cirrhotic patients is less clear. Yanaga et al. found no significant relationship between liver volume and postoperative morbidity or mortality in cirrhotic patients undergoing hepatic resection, 38 presumably because CT scan could not provide a reliable assessment of the severity of cirrhosis. Preoperative evaluation of the severity of cirrhosis by histologic grading of liver fibrosis or measurement of portal pressure has been advocated by some authors. 30, 39 We have not relied on any of these sophisticated or invasive preoperative tests in selecting cirrhotic patients for hepatectomy. Instead, laparoscopy was performed routinely to assess the size of the liver remnant and the severity of cirrhosis by the macroscopic appearance of the liver. 16 Laparoscopic assessment is of particular value in selecting cirrhotic patients for extended hepatectomy, but its reliability depends very much on the experience of the surgeon. For patients without underlying chronic liver disease, preoperative portal vein embolization has been used in some centers to induce hypertrophy of the liver remnant before major or extended hepatectomy. 36, 37 Its effect may be less in cirrhotic liver, 40 but a recent study has shown that portal vein embolization before major hepatic resection was effective in increasing the size of the liver remnant even in patients with cirrhosis. 41 Preoperative portal vein embolization may in-crease the safety of extended hepatectomy for HCC in cirrhotic patients, especially in those with borderline liver remnant size, but such an approach requires further evaluation with prospective studies.
Apart from attention to preoperative liver function and the size of the liver remnant, meticulous surgical techniques are instrumental to safe extended hepatectomy in cirrhotic liver. Extended hepatectomy is associated with an increased risk of hemorrhage, as reflected by the increased blood loss and transfusion rate in group A in the current study. The main source of hemorrhage in extended hepatectomy was bleeding from hepatic veins or the inferior vena cava, especially when resecting a large tumor related to the cavohepatic junction. Extrahepatic control of hepatic veins helps reduce the risk of hemorrhage. This is usually possible for the right or left hepatic vein, but the middle hepatic vein often has to be controlled within the liver during transection. The venous phase of a helical CT scan can provide an accurate anatomical relationship between the tumor and major intrahepatic vessels. A careful appraisal of this relationship is essential for the safe performance of extended hepatectomy. Intraoperative ultrasound helps to clarify the vascular anatomy in relation to the tumor and allows precise delineation of the transection plane. In recent years, we have used the endovascular linear cutter to divide and staple the main trunk of hepatic veins either extrahepatically or intrahepatically. In accordance with others' experience, 42 we found this a quick and safe technique that has never caused any misadventure so far in our patients. This technique is helpful in avoiding injury to the hepatic vein that can occur with the application of vascular clamps in the deep transection plane, especially when the exposure is restricted by a large tumor. In selected cases with exceptionally large right lobe tumors, we used the anterior approach, which helps to reduce blood loss by avoiding iatrogenic tumor rupture and avulsion of hepatic veins during mobilization of the right lobe. 17 We also used portal clamping to reduce bleeding from inflow in some patients, but we did not use total vascular exclusion. The latter technique has been advocated by some authors for extended hepatectomy. 43, 44 It has been shown to be tolerable in cirrhotic patients. 45 However, in a randomized controlled trial, total vascular exclusion resulted in similar intraoperative blood loss but a higher postoperative complication rate compared with portal clamping. 46 In agreement with some authors, 47 we found that hepatic resection could be performed safely without total vascular exclusion even in patients with tumors situated around the cavohepatic junction.
Extended hepatectomy has also been associated with an increased risk of biliary damage and fistula. 11, 48 The biliary anatomy may be grossly distorted by large tumors. In this study, biliary fistula occurred in only one patient (2.2%) in group A. In contrast, a previous study of 25 patients with extended hepatectomy in our institution in the 1980s reported a biliary complication rate of 12%, and devascularization due to dissection and exposure of a considerable Vol. 236 • No. 5
Extended Hepatectomy for HCC in Cirrhosis length of hepatic duct was proposed to be a contributing factor. 11 To avoid the ductal wall being denuded from the glissonian sheath and thus compromised in blood supply, extrahepatic dissection of the hepatic duct is not attempted today. Instead, the hepatic duct pedicle is divided during parenchymal transection, and this may help reduce bile leakage from ischemia of the hepatic duct stump. Accurate delineation of transection plane by intraoperative ultrasound, careful dissection of the hepatic duct pedicle during transection with attention to possible distortion of anatomy, intraoperative cholangiography to define biliary anatomy, and a methylene blue test for bile leakage are other measures that we consider important to prevent biliary damage and postoperative bile leakage.
It has been shown in some studies that the extent of hepatic resection was a significant risk factor for morbidity and mortality after hepatectomy in cirrhotic patients. 35, 49 In contrast, the current study demonstrates no significant differences in postoperative morbidity and mortality between patients with extended hepatic resection and those with lesser resection, but there are certain caveats. It cannot be overemphasized that careful preoperative evaluation of liver function and appraisal of intraoperative findings are important factors for the favorable results in this study. Our early experience with extended hepatectomy in three Child-Pugh class B patients resulted in one hospital death, and we no longer consider extended hepatectomy or any major hepatectomy justified for Child-Pugh class B patients. While there is not yet a single quantitative test that can predict the risk of extended hepatectomy in cirrhotic patients, combined evaluation (liver biochemistry, ICG-R15, and laparoscopic assessment of the liver remnant size and the severity of cirrhosis) has allowed us to select appropriate candidates for extended hepatectomy. The vigilance and skill of the surgeon during the operation and in postoperative management are also critical determinants of the outcome after extended hepatectomy in cirrhotic patients. Hence, such a procedure should be performed only by experienced surgical teams.
To fully justify the role of extended hepatic resection for HCC in cirrhotic patients, it is necessary to demonstrate reasonable long-term survival in addition to perioperative safety. Despite being widely accepted as an effective treatment for HCC in cirrhotic patients, the role of hepatic resection for HCC in cirrhosis has been challenged by some authors. 25, 50 Furthermore, it remains controversial whether major hepatic resection for large HCC is justified. 51 Extended hepatectomy for large HCC in cirrhotic patients is even more debatable. In this study, the long-term overall and disease-free survivals of group A were slightly worse than those of group B, which is understandable given the larger and more advanced tumors in the former group. However, there was no significant difference between the two groups. The 5-year overall survival rate (33%) in cirrhotic patients with extended hepatectomy in the current study appears to be comparable with that reported in some recent series of hepatic resection for HCC in cirrhotic patients. 9, 34, 52 Even for those cirrhotic patients who underwent extended hepatic resection for HCCs larger than 10 cm, the 5-year survival rate of 30% is similar to that reported for resection of HCCs larger than 8 or 10 cm in both cirrhotic and noncirrhotic patients. 51, 53 Such large HCCs are considered contraindications for transplantation or local ablative therapies, and their response to transarterial chemoembolization is poor. 54 Hence, resection for large HCCs in cirrhotic patients is indicated even if extended hepatectomy is required.
In conclusion, this study demonstrates that extended hepatic resection for HCC could be performed in selected cirrhotic patients with morbidity, mortality, and long-term survival results comparable to those of cirrhotic patients who underwent hepatic resection of lesser extent. For large HCCs extending from one lobe into the other or strategically located central HCCs that may otherwise be considered unresectable, extended hepatic resection is a safe and effective treatment in cirrhotic patients with adequate hepatic function reserve and liver remnant size.
